Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
Key Finding
Showed Selank protects against ethanol-induced memory impairment by regulating BDNF levels in the brain, supporting its neuroprotective and cognitive-enhancing properties.
Key Takeaways
- Selank protected memory and brain function from alcohol-related damage.
- It preserved a key brain growth factor that alcohol normally depletes.
- This supports its role as a brain-protective and focus-enhancing peptide.
Study Breakdown
Alcohol-induced cognitive impairment is a significant concern for individuals with alcohol use disorders, and finding neuroprotective agents that can preserve brain function is a clinical priority. This study by Kolik, Nadorova, Antipova, and colleagues investigated whether Selank could protect against ethanol-induced memory impairment in rats.
The researchers administered Selank to rats exposed to ethanol and assessed memory performance using established behavioral tests. Critically, they also measured brain-derived neurotrophic factor (BDNF) levels in the hippocampus and prefrontal cortex, two brain regions essential for memory formation and cognitive function.
The results showed that Selank effectively protects against ethanol-induced memory impairment by regulating BDNF content in key brain regions. The peptide preserved BDNF levels that would otherwise be depleted by alcohol exposure, maintaining the neurotrophin signaling necessary for healthy cognitive function.
These findings support Selank's neuroprotective and cognitive-enhancing properties through a well-characterized biological mechanism. For individuals seeking to protect cognitive function, Selank's ability to maintain BDNF levels in the brain positions it as a promising peptide for supporting neurological health and resilience.
Read the full study on PubMed for complete methodology, data, and citations.
View Full Study on PubMedPMID: 31625062
About Selank
A synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, developed in Russia for its anxiolytic and nootropic properties.
Learn more about Selank →More Selank Research
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
Konstantinopolsky MA, Chernyakova IV, Kolik LG — Bulletin of experimental biology and medicine · 2022 Oct
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity
Vyunova TV, Andreeva L, Shevchenko K, et al. — Protein and peptide letters · 2018
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
Kasian A, Kolomin T, Andreeva L, et al. — Behavioural neurology · 2017
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Filatova E, Kasian A, Kolomin T, et al. — Frontiers in pharmacology · 2017
Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation
Kolik LG, Nadorova AV, Kozlovskaya MM — Bulletin of experimental biology and medicine · 2014 May
Interested in how this research applies to your health goals?
Consult Dr. TaylorDisclaimer: This summary is for educational purposes only and is not medical advice. The study breakdown is a simplified overview of the published research. For complete methodology and data, refer to the original publication on PubMed. Always consult with a qualified healthcare provider before making medical decisions.